Mounjaro Contributed To A Reduction Of 60 Pounds In Average Body Weight For Individuals Suffering From Obesity

Mounjaro Contributed To A Reduction Of 60 Pounds In Average Body Weight For Individuals Suffering From Obesity

According to clinical trial findings released over the weekend, individuals with obesity who underwent a rigorous lifestyle intervention followed by treatment with the appetite-suppressing drug tirzepatide(Mounjaro) experienced a 26% reduction in their body weight over the 84-week program.


What to know about Mounjaro?

The medication tirzepatide, marketed under the brand name Mounjaro, has been approved by the Food and Drug Administration (FDA) for treating type 2 diabetes. However, previous studies have indicated its potential effectiveness as a treatment for obesity.

Obesity medicine specialists have observed a significant rise in the off-label usage of tirzepatide for obesity treatment.FDA approval of tirzepatide for obesity treatment would ideally expand access to those who could benefit from this treatment.

Why You Need Mounjaro to Lose Weight?

The researchers observed that conventional methods such as diet and exercise often fail to achieve the significant weight loss necessary to mitigate the potentially life-threatening health hazards associated with being overweight or obese. Furthermore, even if individuals manage to achieve substantial weight loss through diet and exercise, the majority tend to regain approximately one-third of the lost weight within a year, as highlighted by the authors.

How Long Does It Take For Mounjaro To Take Effect?

Throughout the 12-week period focused on diet and exercise, participants in the study adhered to a calorie-restricted diet, engaged in 150 minutes of physical activity per week, and attended counseling sessions.

Does Mounjaro Have Any Side Effects?

The study authors reported that the most frequent side effects experienced while taking the medication were digestive issues, the majority of which were mild to moderate in intensity.

How Tirzepatide (Mounjaro) works?

Tirzepatide shares similarities with another widely recognized weight loss medication named semaglutide. Semaglutide serves as the active component in the diabetes medication Ozempic and the weight loss medication Wegovy. Both semaglutide and tirzepatide imitate naturally-occurring hormones within the body that govern how the brain controls an individual's appetite.

How much does Mounjaro cost?

Acquiring Mounjaro, Ozempic, and Wegovy can pose challenges due to supply shortages, and the out-of-pocket cost is typically no less than $900 per month or higher.